DIN 02242971 — AMIKACIN SULFATE INJECTION USP 250 MG
AMIKACIN SULFATE INJECTION USP is a liquid of Amikacin marketed by SANDOZ CANADA INCORPORATED. The full Amikacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02242971
- Brand name
- AMIKACIN SULFATE INJECTION USP
- Active ingredient
- Amikacin
- Strength
- 250 MG
- Dosage form
- LIQUID
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Aminoglycoside antibiotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Amikacin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02486717 | AMIKACIN SULFATE INJECTION | 250 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02529459 | AMIKACIN SULFATE INJECTION | 250 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02481073 | AMIKACIN SULFATE INJECTION USP | 500 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02506599 | VPI-AMIKACIN | 500 MG | SOLUTION | VPI PHARMACEUTICALS INC | DORMANT |